VIA
MBOT icon

Vantage Investment Advisors’s Microbot Medical MBOT Stock Holding History

Vantage Investment Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1
Closed -$2K – 850
2014
Q4 		$2K Hold
1
– – ﹤0.01% 704
2014
Q3 		$3K Hold
1
– – ﹤0.01% 626
2014
Q2 		$4K Hold
1
– – ﹤0.01% 599
2014
Q1 		$1K Hold
1
– – ﹤0.01% 637
2013
Q4 		$1K Buy
+1
New +$2.12K ﹤0.01% 616

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Vantage Investment Advisors's MBOT Position: Q1 2015 in Review

Vantage Investment Advisors sold out of Microbot Medical (MBOT) in Q1 2015, closing a stake of 1 share — an estimated $2K sold.

Vantage Investment Advisors first reported a position in MBOT in Q4 2013 and held it in 5 quarters. The position peaked at $4K in Q2 2014. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2015.

  • Vantage Investment Advisors reported no remaining Microbot Medical position as of Q1 2015 after selling out during the quarter.
  • Vantage Investment Advisors sold 1 Microbot Medical share in Q1 2015, an estimated $2K.
  • Vantage Investment Advisors first reported a position in Microbot Medical in Q4 2013 and held it in 5 quarters.
  • Vantage Investment Advisors's Microbot Medical position peaked at $4K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2015.

Based on Vantage Investment Advisors's 13F filing for Q1 2015, filed 4 May 2015.